Introduction
Industrial polyols are sugar alcohols that are used in the pharmaceutical, chemical and food-ingredient industries. Mannitol is used as a low-caloric and low-cariogenic sweetener (in particular in diabetic foodstuffs), as a pharmaceutical formulating agent (e.g. as a diuretic in the manufacture of intravenous fluids and tablets, in dental hygiene products and as a low-reactivity drug filler; Le & Mulderrig, 2001) and as a specialty chemical in other types of industries (Soetaert et al., 1995; Le & Mulderrig, 2001) . SpecChemOnline estimates the global market for mannitol to be about 22 million Euros (Challener, 2004) . Currently, 50 000 tons per year of mannitol are produced by the hydrogenation of 50% fructose/50% glucose syrup at high pressures and temperatures using a Raney nickel catalyst (Kulbe et al., 1987; Soetaert et al., 1999) . The fructose/glucose syrup is converted to a 30% mannitol/70% sorbitol mixture, from which mannitol is purified by low-temperature crystallization (Soetaert et al., 1999) . Developing new simplified biological processes for mannitol production could lower production costs, increase the chemical yield and lower the downstream processing costs. Biological synthesis routes are now being developed (Kaup et al., 2005; Silveira & Jonas, 2002; Soetaert et al., 1999) to lower production costs.
Mannitol is produced enzymatically from fructose by mannitol dehydrogenase (MtDH) using NAD(P)H as the cofactor (Jö rnvall et al., 1984 (Jö rnvall et al., , 1987 Schneider & Giffhorn, 1989; Slatner et al., 1999) . Many MtDH-encoding genes have been cloned and sequenced; their enzymes have been purified and characterized (Aarnikunnas et al., 2002; Brü nker et al., 1997; Sasaki et al., 2005; Schafer et al., 1997; Schneider & Giffhorn, 1989; Stoop & Mooibroek, 1998) . These enzymes belong to three different dehydrogenase/reductase families. Firstly, some fungal MtDHs belong to the short-chain dehydrogenase/ reductase family (Hö rer et al., 2001; Suvarna et al., 2000) . These fungal MtDHs do not require metals for catalysis and contain a conserved catalytic triad (Hö rer et al., 2001; Persson et al., 1991) . Secondly, the medium-chain dehydrogenase/reductase family contains some bacterial MtDHs (Aarnikunnas et al., 2002) . These enzymes are often zinc-dependent enzymes (Nordling et al., 2002; Sasaki et al., 2005) . Thirdly, other bacterial MtDHs belong to a polyol-specific long-chain dehydrogenase group (Schneider et al., 1993) . These long-chain MtDHs are often monomeric; they are characterized by the catalytic consensus motif Lys-Xaa(4/5)-Asn-Xaa(2)-His and do not require metals for catalysis (Kavanagh et al., 2002a,b; Klimacek & Nidetzky, 2002) . The X-ray structures of biological routes being currently developed for mannitol production use medium-chain MtDHs (Kaup et al., 2005; Soetaert et al., 1999) . Thus, it is important to understand the structure-function relationships in this group of enzymes, particularly if enzyme engineering is required for process optimization. For this reason, we cloned and characterized the medium-chain MtDH from the hyperthermophilic bacterium Thermotoga maritima (Song et al., in preparation). T. maritima MtDH (TmMtDH, GenBank No. TM0298) shares 32% identity and 55% similarity with the mesophilic medium-chain Leuconostoc mesenteroides and Lactobacillus reuteri MtDHs. TmMtDH is optimally active at temperatures above 363 K. It reduces fructose optimally at pH 6.0, while it oxidizes mannitol optimally at pH 8.3. This NADH-dependent enzyme also shows activity with NADPH, but with a threefold lower affinity for this cofactor (Song et al., in preparation) ; NADH is also a more economically viable cofactor for industrial use than NADPH. Here, we describe the crystallization conditions, characterization and initial structural analysis of TmMtDH crystals.
Experimental results

TmMtDH expression and purification
The T. maritima mtdh gene was cloned into the NdeI and XhoI sites of pET24a(+) (Novagen, Madison, WI, USA) to yield pTmMtDH (Song et al., in preparation) . From this construct, TmMtDH is expressed with a C-terminal His tag. To produce TmMtDH, Escherichia coli BL21(DE3) cells (Novagen) containing pTmMtDH were grown in 1 l super broth (24 g yeast extract, 12 g tryptone, 13 ml glycerol, 1 mM MgSO 4 , 15.3 g K 2 HPO 4 and 1.7 g KH 2 PO 4 per litre) containing 50 mg ml À1 kanamycin at 310 K. TmMtDH expression was induced at an OD 600 of 1.4 by adding 0.6 mM isopropyl thiogalactoside and growth continued for a further 16 h. After centrifugation (4000g, 10 min), the cell pellet was resuspended (3 ml buffer per gram of wet pellet) in 50 mM 3-(Nmorpholino)propanesulfonic acid (MOPS) pH 7.0 containing 5 mM -mercaptoethanol and protease inhibitors (Complete Mini, Roche Diagnostics, Indianapolis, IN, USA). Cells were disrupted by two passes through a French pressure cell using a pressure drop of 96 MPa. After centrifugation (25 000g, 30 min), the supernatant was heat treated at 358 K for 20 min and then centrifuged again (20 000g, 20 min). The heat-treated extract was then loaded onto a 20 ml nickel-nitrilotriacetic acid agarose (Qiagen, Valencia, CA, USA) column. TmMtDH purification from this column followed the Gibco BRL procedure for Protein Expression System, pRoEX-1 vector (catalogue No. 10197-010, Gaithersburg, MD, USA), washing with 20 volumes of buffer A, five volumes of buffer B and five volumes buffer of A before eluting with 5-10 volumes of buffer C. The purified protein was dialyzed against 50 mM MOPS pH 7.0 containing 5 mM -mercaptoethanol and stored frozen at 203 K. Protein purity was assessed on an SDS-PAGE gel after staining with Coomassie blue. Protein concentrations were quantified using the Biorad Protein Dye (Biorad, Hercules, CA, USA) with using bovine serum albumin as the standard.
TmMtDH crystallization
10 mg ml À1 TmMtDH protein in 50 mM Tris pH 8.5 buffer solution was screened at room temperature against the MPD and Classics screening kits from Nextal Biotechnologies (Montreal, Canada) using the microbatch-under-oil method. Drops were formed by mixing an equal volume of TmMtDH protein solution and MPD screening kit solution and were covered with 100% mineral oil. The protein crystallized in two Nextal Classics conditions, but the largest and most defined crystals were found in the MPD screening kit solution G4 (30% MPD, 0.1 M Na HEPES pH 7.5). The C-terminal His tag was retained on the protein construct prior to crystallization. The MPDgrown crystals were approximately 0.1 Â 0.05 Â 0.05 mm in size and were rectangular in shape (Fig. 1) . Crystals were flash-cooled without additional cryoprotectant because of the high concentration of MPD in the precipitant solution.
TmMtDH diffraction and data collection
Diffraction of the TmMtDH crystals took place at the 08ID-1 protein crystallography beamline at the Canadian Light Source (Saskatoon, Saskatchewan, Canada). The data collected from the TmMtDH crystals are summarized in Table 1 . Intensity data were indexed, integrated and scaled using XDS (Kabsch, 1993) .
Structure solution
A molecular-replacement solution for the diffraction data set from the TmMtDH crystal was found using the 3D-PSSM search engine (Kelly et al., 2000) . The sequence of ketose reductase (sorbitol dehydrogenase) from silverleaf whitefly (PDB code 1e3j) is 24% identical to that of TmMtDH. This identity level is low, so the structure of NADP(+)-dependent Bacillus stearothermophilus 
Figure 1
A TmMtDH crystal. The largest dimension is approximately 0.1 mm. alcohol dehydrogenase (PDB code 1rjw), which has 23% sequence identity with TmMtDH, may also be used to aid in calculating phases using the program Phaser (Storoni et al., 2004) .
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